Cargando…

Relevance of Splicing on Tumor-Released Exosome Landscape: Implications in Cancer Therapeutics

Detalles Bibliográficos
Autor principal:	Oltra, Elisa
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Frontiers Media S.A. 2014
Materias:	Endocrinology
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4228196/ https://www.ncbi.nlm.nih.gov/pubmed/25429285 http://dx.doi.org/10.3389/fendo.2014.00194

Ejemplares similares

Exosomes: Biomarkers and Therapeutic Targets of Diabetic Vascular Complications
por: Chen, Anqi, et al.
Publicado: (2021)

Immune Landscape of Thyroid Cancers: New Insights
por: Menicali, Elisa, et al.
Publicado: (2021)

Role of FGF Receptors and Their Pathways in Adrenocortical Tumors and Possible Therapeutic Implications
por: Sbiera, Iuliu, et al.
Publicado: (2021)

A combined signature of glycolysis and immune landscape predicts prognosis and therapeutic response in prostate cancer
por: Guo, Tao, et al.
Publicado: (2022)

Therapeutic potential of urine exosomes derived from rats with diabetic kidney disease
por: Mishra, Deendayal Das, et al.
Publicado: (2023)

Aberrant PI3Kδ splice isoform as a potential biomarker and novel therapeutic target for endocrine cancers
por: Ha, Siyoung, et al.
Publicado: (2023)

The Emerging Roles and Therapeutic Implications of Epigenetic Modifications in Ovarian Cancer
por: Wang, Yu, et al.
Publicado: (2022)

Alternative Splicing: Expanding the Landscape of Cancer Biomarkers and Therapeutics
por: Bessa, Cláudia, et al.
Publicado: (2020)

Current understanding of the contribution of lactate to the cardiovascular system and its therapeutic relevance
por: Wu, Panyun, et al.
Publicado: (2023)

How to maximize the therapeutic effect of exosomes on skin wounds in diabetes mellitus: Review and discussion
por: Dong, Jia, et al.
Publicado: (2023)

A comprehensive overview of exosome lncRNAs: emerging biomarkers and potential therapeutics in endometriosis
por: Wang, Min, et al.
Publicado: (2023)

The genomic landscape of prostate cancer
por: Baca, Sylvan C., et al.
Publicado: (2012)

Prescribing Characteristics of Octreotide Immediate-Release and Long-Acting Release in Patients with Neuroendocrine Tumors
por: Cheng, Yue, et al.
Publicado: (2023)

Therapeutic potential of exosomes/miRNAs in polycystic ovary syndrome induced by the alteration of circadian rhythms
por: Chen, Wei-hong, et al.
Publicado: (2022)

Gliotransmitter Release from Astrocytes: Functional, Developmental, and Pathological Implications in the Brain
por: Harada, Kazuki, et al.
Publicado: (2016)

Landscape of CDKN1B Mutations in Luminal Breast Cancer and Other Hormone-Driven Human Tumors
por: Cusan, Martina, et al.
Publicado: (2018)

Decoding the Therapeutic Implications of the ERα Stability and Subcellular Distribution in Breast Cancer
por: Tecalco-Cruz, Angeles C., et al.
Publicado: (2022)

Exosomes: Diagnostic and Therapeutic Implications in Cancer
por: Jo, Hyein, et al.
Publicado: (2023)

The landscape and therapeutic relevance of cancer-associated transcript fusions
por: Yoshihara, Kosuke, et al.
Publicado: (2014)

Hyperuricemia and the Risk of Heart Failure: Pathophysiology and Therapeutic Implications
por: Si, Ke, et al.
Publicado: (2021)

Editorial: Cholesterol and Oxysterols as Signal Molecules in Human Pathophysiology and Cancer: Implications for New Therapeutic Strategies
por: Sirianni, Rosa, et al.
Publicado: (2019)

Role of Exosomes in Islet Transplantation
por: Mattke, Jordan, et al.
Publicado: (2021)

Erectile dysfunction and exosome therapy
por: Feng, Huan, et al.
Publicado: (2023)

Editorial: Sexual dimorphism in biomedical research and its therapeutic implications
por: Kroon, Jan, et al.
Publicado: (2022)

Editorial: Monoclonal gammopathies of clinical significance: Clinical and therapeutic implications
por: Wang, Chen, et al.
Publicado: (2023)

The Relevant Participation of Prolactin in the Genesis and Progression of Gynecological Cancers
por: Ramírez-de-Arellano, Adrián, et al.
Publicado: (2021)

Cholesterol and Its Metabolites in Tumor Growth: Therapeutic Potential of Statins in Cancer Treatment
por: Chimento, Adele, et al.
Publicado: (2019)

A Changing Landscape in Castration-Resistant Prostate Cancer Treatment
por: Felici, A., et al.
Publicado: (2012)

The crosstalk within the breast tumor microenvironment in type II diabetes: Implications for cancer disparities
por: Ennis, Christina S., et al.
Publicado: (2022)

New Developments in T Cell Immunometabolism and Therapeutic Implications for Type 1 Diabetes
por: Zhang, Mengdi, et al.
Publicado: (2022)

Evidence for the Possible Biological Significance of the igf-1 Gene Alternative Splicing in Prostate Cancer
por: Philippou, Anastassios, et al.
Publicado: (2013)

Alternative RNA Splicing in the Pathogenesis of Liver Disease
por: Webster, Nicholas J. G.
Publicado: (2017)

Alternative RNA Splicing in Fatty Liver Disease
por: Wu, Panyisha, et al.
Publicado: (2021)

Impact of Nutrient Type and Sequence on Glucose Tolerance: Physiological Insights and Therapeutic Implications
por: Nesti, Lorenzo, et al.
Publicado: (2019)

An update on brown adipose tissue and obesity intervention: Function, regulation and therapeutic implications
por: Liu, Xiaomeng, et al.
Publicado: (2023)

Editorial: The Role of Exosomes in Metabolic and Endocrine Disease
por: Guo, Bei, et al.
Publicado: (2022)

Exosomes: A Friend or Foe for Osteoporotic Fracture?
por: Yang, Zhimin, et al.
Publicado: (2021)

Exosomal RNAs in the development and treatment of pituitary adenomas
por: Chang, Mengqi, et al.
Publicado: (2023)

Prognostic Alternative mRNA Splicing in Adrenocortical Carcinoma
por: Liang, Weiwei, et al.
Publicado: (2021)

Hypoparathyroidism, deafness and renal dysplasia syndrome caused by a GATA3 splice site mutation leading to the activation of a cryptic splice site
por: Gonçalves, Catarina I., et al.
Publicado: (2023)

Cannot write session to /tmp/vufind_sessions/sess_67rrti0e2jpbm58b4mav7t6h1r